US2010099906A1PendingUtilityA1
Generation of endo- and/or exo-norbornenecarboxaldehyde as an intermediate to functionalized norbornenes
Est. expiryNov 5, 2027(~1.3 yrs left)· nominal 20-yr term from priority
C07C 29/14C07C 45/44C07C 51/16C07C 51/285C07C 51/29C07B 2200/09C07C 2602/42
60
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Embodiments in accordance with the present invention provide for forming essentially pure diastereomers of 5/6-substituted norbornene-type monomers. Further, embodiments in accordance with the present invention encompass polymerizing such diastereomers to form addition or ROMP polymers where a desired exo-/endo-ratio of the diastereomers is provided to the polymerization, such ratio designed to provide a desired ratio of endo-/exo-structured repeating units for a resulting polymer to have desired physical or chemical properties.
Claims
exact text as granted — not AI-modified1 . A method for forming essentially pure exo- and/or endo-substituted polycyclic olefin monomers, comprising:
forming a diastereomeric mixture of norbornenecarbonitrile (NBCN) via a Diels-Alder reaction; separating the endo- and exo-diastereomers of such diastereomeric mixture; selecting one of the exo- or endo-diastereomers and contacting such selected diastereomer with cyclopentadiene to form the selected tetracyclododecenecarbonitrile (TDCN); first converting such selected TDCN to a tetracyclododecenecarbaldehyde (TDCHO); and second converting the TDCHO to one of a tetracyclododecene carboxylic acid (TDCO 2 H) or a tetracyclododecene methyl alcohol (TDCH 2 OH).
2 . The method of claim 1 , where selecting comprises selecting the exo-diastereomer.
3 . The method of claim 1 , where the first converting comprises charging a reaction vessel with a metal hydride and the selected TDCN diastereomer to effect a reduction of such TDCN diastereomer and subsequently hydrolysing the reaction intermediate.
4 . The method of claim 1 , where the second converting comprises charging a reaction vessel with a hydride donor reagent and an individual exo- or endo-carboaldehyde containing diastereomer to effect a reduction of the exo- or endo-carboaldehyde containing diastereomer.
5 . The method of claim 1 , where the second converting comprises charging a reaction vessel with an appropriate oxidizing agent and an individual exo- or endo-carboaldehyde containing diastereomer to effect an oxidation of the exo- or endo-carboaldehyde containing diastereomer.
6 . The method of claim 3 , where the second converting comprises charging a reaction vessel with an appropriate oxidizing agent and an individual exo- or endo-carboaldehyde containing diastereomer to effect an oxidation of the exo- or endo-carboaldehyde containing diastereomer.
7 . The method of claim 3 , where the second converting comprises charging a reaction vessel with an appropriate reducing agent and an individual exo- or endo-carboaldehyde containing diastereomer to effect a reduction of the exo- or endo-carboaldehyde containing diastereomer.
8 . The method of claim 3 , where the second converting comprises charging a reaction vessel with a hydride donor reagent and an individual exo- or endo-carboaldehyde containing diastereomer to effect a reduction of the exo- or endo-carboaldehyde containing diastereomer.
9 . The method of claim 3 , where the metal hydride comprises lithium aluminum hydride, alkyl aluminum hydrides, alkoxyaluminum hydrides, or dialkylamino lithium hydrides.Join the waitlist — get patent alerts
Track US2010099906A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.